SSWG
XLRN

Seven Springs Wealth Group’s Acceleron Pharma XLRN Stock Holding History

Seven Springs Wealth Group’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-8
Closed -$1K – 274
2020
Q4 		$1K Buy
+8
New +$938 ﹤0.01% 247

Other funds holding XLRN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Seven Springs Wealth Group's XLRN Position: Q1 2021 in Review

Seven Springs Wealth Group sold out of Acceleron Pharma (XLRN) in Q1 2021, closing a stake of 8 shares — an estimated $1K sold.

Seven Springs Wealth Group first reported a position in XLRN in Q4 2020 and held it in 1 quarter. The position peaked at $1K in Q4 2020. 256 funds tracked by Wall St. Rank hold XLRN as of Q1 2021.

  • Seven Springs Wealth Group reported no remaining Acceleron Pharma position as of Q1 2021 after selling out during the quarter.
  • Seven Springs Wealth Group sold 8 Acceleron Pharma shares in Q1 2021, an estimated $1K.
  • Seven Springs Wealth Group first reported a position in Acceleron Pharma in Q4 2020 and held it in 1 quarter.
  • Seven Springs Wealth Group's Acceleron Pharma position peaked at $1K in Q4 2020.
  • 256 funds tracked by Wall St. Rank held Acceleron Pharma as of Q1 2021.

Based on Seven Springs Wealth Group's 13F filing for Q1 2021, filed 7 May 2021.